BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22230262)

  • 1. Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase.
    Herkert NM; Freude G; Kunz U; Thiermann H; Worek F
    Toxicol Lett; 2012 Mar; 209(2):173-8. PubMed ID: 22230262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
    Herkert NM; Aurbek N; Eyer P; Thiermann H; Worek F
    Toxicol Lett; 2010 May; 194(3):94-101. PubMed ID: 20156534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
    Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different buffers on kinetic properties of human acetylcholinesterase and the interaction with organophosphates and oximes.
    Wille T; Thiermann H; Worek F
    Arch Toxicol; 2011 Mar; 85(3):193-8. PubMed ID: 20669006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and guinea pig acetylcholinesterase.
    Worek F; Aurbek N; Wille T; Eyer P; Thiermann H
    Toxicol Lett; 2011 Jan; 200(1-2):19-23. PubMed ID: 20971170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species.
    Luo C; Chambers C; Yang Y; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):185-90. PubMed ID: 20096273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Eckert S; Eyer P; Herkert N; Bumm R; Weber G; Thiermann H; Worek F
    Biochem Pharmacol; 2008 Feb; 75(3):698-703. PubMed ID: 17977518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
    J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oximes as blood-brain barrier penetrating cholinesterase reactivators.
    Garcia GE; Campbell AJ; Olson J; Moorad-Doctor D; Morthole VI
    Chem Biol Interact; 2010 Sep; 187(1-3):199-206. PubMed ID: 20227398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
    Thiermann H; Eyer P; Worek F; Szinicz L
    Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
    Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
    Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
    Worek F; Thiermann H
    Chem Biol Interact; 2011 Nov; 194(2-3):91-6. PubMed ID: 21930118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach.
    Worek F; Wille T; Aurbek N; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2010 Dec; 249(3):231-7. PubMed ID: 20888357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.